15 October 2021 : Clinical Research
The Serum Metabolomics Study of Liver Failure and Artificial Liver Therapy Intervention
Shipeng Huang1ABC, Dali Hu2BCD, Songsong Yuan3BCD, Ying He3BCD, Chengmu Li3BCD, Ying Zhu3BCD, Xiaoping Wu3AEF*DOI: 10.12659/MSM.930638
Med Sci Monit 2021; 27:e930638
Figure 3 Importance of variables in each group. (A) The main different substances in the liver failure group and the healthy group; (B) the main different substances between the chronic hepatitis group and the healthy group; (C) the main different substances before and after artificial liver treatment.